Search - tctmd.com

Displaying 201 - 220 of 671

Sort: Relevancy | Date

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Conference News ESC 2017

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Shelley Wood

August 27, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Daily News

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

Yael L. Maxwell

August 07, 2017

News Daily News

Boston Scientific Scraps Biodegradable Scaffold Program

Michael O'Riordan

August 01, 2017

Presentation

Incidence, Predictors, and Clinical Outcomes of Early Stent Thrombosis After Primary PCI

July 28, 2017

News Daily News

Real-World STEMI Study Shows Low Rate of Early Stent Thrombosis After Primary PCI

Todd Neale

July 28, 2017

News Daily News

Despite the Strengths of Next-Gen DES, BMS Deserve a Place at the Cath Table, Review Asserts

Caitlin E. Cox

July 28, 2017

News Industry News

Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent

July 25, 2017

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Shelley Wood

July 21, 2017

News Daily News

Advanced Age Shouldn’t Be a Barrier to PCI, Study Suggests

Ashley Lyles

July 07, 2017

News Daily News

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Yael L. Maxwell

June 30, 2017

News Daily News

New-Generation DES Work Just Fine in Women With Acute MI

Todd Neale

June 29, 2017

Podcast

Episode 14: ABSORB II, the Future of BRS, and Post-TAVR Thrombosis

June 07, 2017

News Conference News EuroPCR 2017

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Shelley Wood

June 02, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

Advertisement

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year

Boston Scientific Scraps Biodegradable Scaffold Program

Incidence, Predictors, and Clinical Outcomes of Early Stent Thrombosis After Primary PCI

Real-World STEMI Study Shows Low Rate of Early Stent Thrombosis After Primary PCI

Despite the Strengths of Next-Gen DES, BMS Deserve a Place at the Cath Table, Review Asserts

Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Advanced Age Shouldn’t Be a Barrier to PCI, Study Suggests

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

New-Generation DES Work Just Fine in Women With Acute MI

Episode 14: ABSORB II, the Future of BRS, and Post-TAVR Thrombosis

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content